Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Linn

Showing results (201-210 of 467) with videos related to

Pageof 47
Sort By:
The British Journal of Radiology|June 18, 2021
Prognostic value of breast MRI characteristics before and during neoadjuvant endocrine therapy in patients with ER+/HER2- breast cancerMax Aa Ragusi, Gonneke Ao Winter-Warnars, Jelle Wesseling, et al.
Genomics|August 1, 1994
Molecular cloning and physical and genetic mapping of the human anion exchanger isoform 3 (SLC2C) gene to chromosome 2q36Y R Su, C A Klanke, T W Houseal, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2020
Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trialValesca P Retèl, Danalyn Byng, Sabine C Linn, et al.
Bone Marrow Transplantation|February 11, 2009
Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcomeA S Babatunde, D C L Tan, K K Heng, et al.
Genome Medicine|January 6, 2019
Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNAMeiling Gao, Maurizio Callari, Emma Beddowes, et al.
Human Brain Mapping|November 19, 2011
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imagingMichiel B de Ruiter, Liesbeth Reneman, Willem Boogerd, et al.
Biochemical Pharmacology|October 20, 2019
Butyrylcholinesterase, a stereospecific in vivo bioscavenger against nerve agent intoxicationDouglas M Cerasoli, Stuart J Armstrong, Tony E Reeves, et al.
Molecular Oncology|July 5, 2018
FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcomeWillemijne Schrijver, Karianne Schuurman, Annelot van Rossum, et al.
Annals of Surgical Oncology|April 8, 2010
The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapyM E Straver, E J Th Rutgers, S Rodenhuis, et al.
Advances in Hematology|December 5, 2009
Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemiaWilliam Y K Hwang, Claire Dearden, Yvonne S M Loh, et al.
Pageof 47

Showing results (201-210 of 467) with videos related to

Sort By:
Pageof 47
The British Journal of Radiology|June 18, 2021
Prognostic value of breast MRI characteristics before and during neoadjuvant endocrine therapy in patients with ER+/HER2- breast cancerMax Aa Ragusi, Gonneke Ao Winter-Warnars, Jelle Wesseling, et al.
Genomics|August 1, 1994
Molecular cloning and physical and genetic mapping of the human anion exchanger isoform 3 (SLC2C) gene to chromosome 2q36Y R Su, C A Klanke, T W Houseal, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2020
Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trialValesca P Retèl, Danalyn Byng, Sabine C Linn, et al.
Bone Marrow Transplantation|February 11, 2009
Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcomeA S Babatunde, D C L Tan, K K Heng, et al.
Genome Medicine|January 6, 2019
Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNAMeiling Gao, Maurizio Callari, Emma Beddowes, et al.
Human Brain Mapping|November 19, 2011
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imagingMichiel B de Ruiter, Liesbeth Reneman, Willem Boogerd, et al.
Biochemical Pharmacology|October 20, 2019
Butyrylcholinesterase, a stereospecific in vivo bioscavenger against nerve agent intoxicationDouglas M Cerasoli, Stuart J Armstrong, Tony E Reeves, et al.
Molecular Oncology|July 5, 2018
FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcomeWillemijne Schrijver, Karianne Schuurman, Annelot van Rossum, et al.
Annals of Surgical Oncology|April 8, 2010
The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapyM E Straver, E J Th Rutgers, S Rodenhuis, et al.
Advances in Hematology|December 5, 2009
Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemiaWilliam Y K Hwang, Claire Dearden, Yvonne S M Loh, et al.
Pageof 47